- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: 1361.32%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | -0.22 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2022 (9) | 0.01 | -99.63 | 0.65 | -23.53 | 0.00 | 0 | 6500.00 | 20776.47 | 0.00 | 0 | 6500.00 | 8350.0 |
| 2021 (8) | 2.73 | 313.64 | 0.85 | 70.0 | 1.25 | 0 | 31.14 | -58.9 | 45.79 | 0 | 76.92 | 1.54 |
| 2020 (7) | 0.66 | 6.45 | 0.50 | 0.0 | 0.00 | 0 | 75.76 | -6.06 | 0.00 | 0 | 75.76 | -6.06 |
| 2019 (6) | 0.62 | -50.79 | 0.50 | -66.67 | 0.00 | 0 | 80.65 | -32.26 | 0.00 | 0 | 80.65 | -32.26 |
| 2018 (5) | 1.26 | -23.17 | 1.50 | 50.0 | 0.00 | 0 | 119.05 | 95.24 | 0.00 | 0 | 119.05 | 95.24 |
| 2017 (4) | 1.64 | -30.51 | 1.00 | 11.11 | 0.00 | 0 | 60.98 | 59.89 | 0.00 | 0 | 60.98 | 59.89 |
| 2016 (3) | 2.36 | 191.36 | 0.90 | 12.5 | 0.00 | 0 | 38.14 | -61.39 | 0.00 | 0 | 38.14 | -61.39 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 0.49 | 250.0 | 322.73 | 0.66 | 94.12 | 407.69 | 0.88 | 125.64 | 235.38 |
| 24Q2 (19) | 0.14 | -44.0 | 156.0 | 0.34 | -33.33 | 54.55 | 0.39 | 56.0 | 190.7 |
| 24Q1 (18) | 0.25 | -41.86 | 238.89 | 0.51 | -48.48 | 168.42 | 0.25 | 213.64 | 238.89 |
| 23Q4 (17) | 0.43 | 295.45 | 368.75 | 0.99 | 661.54 | 450.0 | -0.22 | 66.15 | -2300.0 |
| 23Q3 (16) | -0.22 | 12.0 | 64.52 | 0.13 | -40.91 | 136.11 | -0.65 | -51.16 | -482.35 |
| 23Q2 (15) | -0.25 | -38.89 | -377.78 | 0.22 | 15.79 | -21.43 | -0.43 | -138.89 | -148.31 |
| 23Q1 (14) | -0.18 | -12.5 | -122.78 | 0.19 | 5.56 | -78.41 | -0.18 | -1900.0 | -122.78 |
| 22Q4 (13) | -0.16 | 74.19 | -130.19 | 0.18 | 150.0 | -70.49 | 0.01 | -94.12 | -99.63 |
| 22Q3 (12) | -0.62 | -788.89 | -293.75 | -0.36 | -228.57 | -176.92 | 0.17 | -80.9 | -92.27 |
| 22Q2 (11) | 0.09 | -88.61 | -91.96 | 0.28 | -68.18 | -76.27 | 0.89 | 12.66 | -52.41 |
| 22Q1 (10) | 0.79 | 49.06 | 3.95 | 0.88 | 44.26 | 2.33 | 0.79 | -71.06 | 3.95 |
| 21Q4 (9) | 0.53 | 65.62 | -36.9 | 0.61 | 569.23 | -33.7 | 2.73 | 24.09 | 313.64 |
| 21Q3 (8) | 0.32 | -71.43 | 146.15 | -0.13 | -111.02 | -144.83 | 2.20 | 17.65 | 1322.22 |
| 21Q2 (7) | 1.12 | 47.37 | 283.61 | 1.18 | 37.21 | 594.12 | 1.87 | 146.05 | 703.23 |
| 21Q1 (6) | 0.76 | -9.52 | 153.33 | 0.86 | -6.52 | 104.76 | 0.76 | 15.15 | 153.33 |
| 20Q4 (5) | 0.84 | 546.15 | 394.12 | 0.92 | 217.24 | 217.24 | 0.66 | 466.67 | 6.45 |
| 20Q3 (4) | 0.13 | 121.31 | 0.0 | 0.29 | 70.59 | 0.0 | -0.18 | 41.94 | 0.0 |
| 20Q2 (3) | -0.61 | -303.33 | 0.0 | 0.17 | -59.52 | 0.0 | -0.31 | -203.33 | 0.0 |
| 20Q1 (2) | 0.30 | 76.47 | 0.0 | 0.42 | 44.83 | 0.0 | 0.30 | -51.61 | 0.0 |
| 19Q4 (1) | 0.17 | 0.0 | 0.0 | 0.29 | 0.0 | 0.0 | 0.62 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 1.6 | -5.87 | -27.35 | 19.22 | 4.6 | 5.36 | N/A | - | ||
| 2024/9 | 1.7 | -17.77 | -14.92 | 17.62 | 8.94 | 6.11 | 0.59 | - | ||
| 2024/8 | 2.07 | -11.94 | 3.77 | 15.92 | 12.31 | 6.22 | 0.58 | - | ||
| 2024/7 | 2.35 | 29.77 | 11.89 | 13.86 | 13.7 | 6.22 | 0.58 | - | ||
| 2024/6 | 1.81 | -12.65 | -4.56 | 11.51 | 14.08 | 5.55 | 0.62 | - | ||
| 2024/5 | 2.07 | 23.76 | 21.02 | 9.7 | 18.39 | 5.83 | 0.59 | - | ||
| 2024/4 | 1.67 | -19.95 | 1.52 | 7.63 | 17.7 | 5.25 | 0.66 | - | ||
| 2024/3 | 2.09 | 40.01 | 21.61 | 5.96 | 23.21 | 5.96 | 0.49 | - | ||
| 2024/2 | 1.49 | -37.2 | 4.33 | 3.87 | 24.09 | 5.99 | 0.49 | - | ||
| 2024/1 | 2.38 | 12.08 | 40.84 | 2.38 | 40.84 | 6.64 | 0.44 | - | ||
| 2023/12 | 2.12 | -1.01 | 14.35 | 22.64 | -2.98 | 6.46 | 0.42 | - | ||
| 2023/11 | 2.14 | -2.67 | 52.78 | 20.52 | -4.48 | 6.34 | 0.43 | 去年同期受客戶消化庫存影響，營收降低所致。 | ||
| 2023/10 | 2.2 | 10.23 | 37.1 | 18.38 | -8.48 | 6.19 | 0.44 | - | ||
| 2023/9 | 2.0 | 0.31 | 36.09 | 16.17 | -12.44 | 6.08 | 0.58 | - | ||
| 2023/8 | 1.99 | -5.05 | 16.87 | 14.18 | -16.63 | 5.98 | 0.59 | - | ||
| 2023/7 | 2.1 | 10.68 | 16.62 | 12.19 | -20.36 | 5.7 | 0.62 | - | ||
| 2023/6 | 1.89 | 10.75 | 15.69 | 10.09 | -25.29 | 5.25 | 0.76 | - | ||
| 2023/5 | 1.71 | 3.82 | -21.91 | 8.19 | -30.94 | 5.08 | 0.78 | - | ||
| 2023/4 | 1.65 | -4.11 | -27.16 | 6.48 | -32.99 | 4.8 | 0.83 | - | ||
| 2023/3 | 1.72 | 20.11 | -38.21 | 4.84 | -34.77 | 4.84 | 0.95 | - | ||
| 2023/2 | 1.43 | -15.23 | -29.0 | 3.12 | -32.7 | 4.97 | 0.92 | - | ||
| 2023/1 | 1.69 | -8.99 | -35.54 | 1.69 | -35.54 | 4.94 | 0.93 | - | ||
| 2022/12 | 1.85 | 32.25 | -30.16 | 23.34 | -4.64 | 4.86 | 1.17 | - | ||
| 2022/11 | 1.4 | -12.66 | -43.55 | 21.48 | -1.53 | 4.48 | 1.28 | - | ||
| 2022/10 | 1.61 | 9.41 | 8.21 | 20.08 | 3.85 | 4.78 | 1.2 | - | ||
| 2022/9 | 1.47 | -13.85 | 32.96 | 18.47 | 3.49 | 4.97 | 1.37 | - | ||
| 2022/8 | 1.7 | -5.25 | 111.26 | 17.01 | 1.55 | 5.14 | 1.33 | 去年同期因受越南疫情影響營收減少 | ||
| 2022/7 | 1.8 | 9.8 | -19.32 | 15.3 | -3.99 | 5.63 | 1.21 | - | ||
| 2022/6 | 1.64 | -25.24 | -35.21 | 13.5 | -1.5 | 6.09 | 1.22 | - | ||
| 2022/5 | 2.19 | -3.16 | -9.27 | 11.87 | 6.11 | 7.23 | 1.03 | - | ||
| 2022/4 | 2.26 | -18.65 | -9.21 | 9.68 | 10.34 | 7.06 | 1.05 | - | ||
| 2022/3 | 2.78 | 38.01 | 22.22 | 7.41 | 18.11 | 7.41 | 1.04 | - | ||
| 2022/2 | 2.02 | -23.04 | 23.98 | 4.63 | 15.78 | 7.29 | 1.06 | - | ||
| 2022/1 | 2.62 | -1.4 | 10.17 | 2.62 | 10.17 | 7.76 | 1.0 | - | ||
| 2021/12 | 2.66 | 6.91 | 21.57 | 24.47 | 24.57 | 6.62 | 1.28 | - | ||
| 2021/11 | 2.48 | 67.42 | 17.75 | 21.82 | 24.95 | 5.07 | 1.67 | - | ||
| 2021/10 | 1.48 | 34.43 | -24.69 | 19.33 | 25.94 | 3.39 | 2.49 | - | ||
| 2021/9 | 1.1 | 36.86 | -38.75 | 17.85 | 33.4 | 4.14 | 2.04 | - | ||
| 2021/8 | 0.81 | -63.82 | -51.28 | 16.75 | 44.63 | 5.56 | 1.52 | 因受越南疫情影響營收減少 | ||
| 2021/7 | 2.23 | -11.82 | 53.81 | 15.94 | 60.62 | 7.17 | 1.18 | 去年同期受新冠肺炎疫情影響，營收大幅減少。 | ||
| 2021/6 | 2.53 | 4.69 | 169.77 | 13.71 | 61.79 | 7.43 | 0.95 | 去年同期受新冠肺炎疫情影響，營收大幅減少。 | ||
| 2021/5 | 2.41 | -3.1 | 223.27 | 11.18 | 48.37 | 7.18 | 0.98 | 去年同期受新冠肺炎疫情影響，營收大幅減少。 | ||
| 2021/4 | 2.49 | 9.51 | 56.76 | 8.77 | 29.13 | 6.39 | 1.1 | 去年同期受新冠肺炎疫情影響，營收大幅減少。 | ||
| 2021/3 | 2.28 | 40.0 | 14.09 | 6.28 | 20.69 | 6.28 | 0.88 | - | ||
| 2021/2 | 1.63 | -31.62 | 16.24 | 4.0 | 24.79 | 6.19 | 0.89 | - | ||
| 2021/1 | 2.38 | 8.8 | 31.4 | 2.38 | 31.4 | 6.67 | 0.82 | - | ||
| 2020/12 | 2.18 | 3.54 | 11.96 | 19.64 | -10.27 | 6.26 | 0.57 | - | ||
| 2020/11 | 2.11 | 7.06 | 32.35 | 17.46 | -12.45 | 5.88 | 0.61 | - | ||
| 2020/10 | 1.97 | 9.34 | 19.56 | 15.35 | -16.34 | 5.43 | 0.66 | - | ||
| 2020/9 | 1.8 | 8.85 | 2.92 | 13.38 | -19.89 | 4.91 | 0.68 | - | ||
| 2020/8 | 1.66 | 14.23 | -17.5 | 11.58 | -22.56 | 4.04 | 0.82 | - | ||
| 2020/7 | 1.45 | 54.64 | -23.92 | 9.92 | -23.34 | 3.13 | 1.06 | - | ||
| 2020/6 | 0.94 | 25.45 | -51.24 | 8.47 | -23.24 | 3.27 | 1.23 | 主要客戶受新冠肺炎影響，客戶延緩或取消訂單，致業績受影響。 | ||
| 2020/5 | 0.75 | -53.01 | -61.49 | 7.54 | -17.34 | 4.33 | 0.93 | 主要客戶受新冠肺炎影響，客戶延緩或取消訂單，致業績受影響。 | ||
| 2020/4 | 1.59 | -20.3 | -17.92 | 6.79 | -5.41 | 4.98 | 0.81 | - | ||
| 2020/3 | 1.99 | 42.64 | 8.9 | 5.2 | -0.79 | 5.2 | 0.73 | - | ||
| 2020/2 | 1.4 | -22.69 | 9.36 | 3.21 | -5.99 | 5.16 | 0.74 | - | ||
| 2020/1 | 1.81 | -7.29 | -15.21 | 1.81 | -15.21 | 5.35 | 0.71 | - | ||
| 2019/12 | 1.95 | 22.4 | 12.2 | 21.9 | 0.32 | 0.0 | N/A | - | ||
| 2019/11 | 1.59 | -3.28 | -6.08 | 19.94 | -0.7 | 0.0 | N/A | - |
